Jump to content Main menu Main menu move to sidebar hide Navigation Main page Contents Current events Random article About Wikipedia Contact us Contribute Help Learn to edit Community portal Recent changes Upload file Special pages Search Search Appearance Donate Create account Log in Personal tools Donate Create account Log in Pages for logged out editors learn more Contributions Talk CentralNotice Contents move to sidebar hide (Top) 1 Research 2 Citations 3 Awards 4 Affiliations 5 References 6 External links Toggle the table of contents Bert Vogelstein 14 languages العربية تۆرکجه Català Deutsch Español فارسی Français Nederlands 日本語 Norsk bokmål Português Русский Українська 中文 Edit links Article Talk English Read Edit View history Tools Tools move to sidebar hide Actions Read Edit View history General What links here Related changes Upload file Permanent link Page information Cite this page Get shortened URL Download QR code Print/export Download as PDF Printable version In other projects Wikimedia Commons Wikidata item Appearance move to sidebar hide From Wikipedia, the free encyclopedia American oncologist (born 1949) Bert Vogelstein Born ( 1949-06-02 ) June 2, 1949 (age 76) Baltimore, Maryland , U.S.

Education University of Pennsylvania Johns Hopkins School of Medicine Known for p53, Vogelgram, somatic evolution in cancer Spouse Ilene Vogelstein Children R. Jacob Vogelstein, Joshua T. Vogelstein , and one more, Grandchildren: 5 Awards Breakthrough Prize in Life Sciences (2013) [ 1 ] Warren Triennial Prize (2014) [ 2 ] Scientific career Fields Oncology , Pathology Institutions Johns Hopkins School of Medicine Doctoral students Kenneth Kinzler [ 3 ] Website www .hhmi .org /scientists /bert-vogelstein Bert Vogelstein (born 1949) is director of the Ludwig Center, Clayton Professor of Oncology and Pathology and a Howard Hughes Medical Institute investigator at The Johns Hopkins Medical School and Sidney Kimmel Comprehensive Cancer Center .

[ 4 ] A pioneer in the field of cancer genomics , his studies on colorectal cancers revealed that they result from the sequential accumulation of mutations in oncogenes and tumor suppressor genes . These studies now form the paradigm for modern cancer research and provided the basis for the notion of the somatic evolution of cancer.

Research [ edit ] In the 1980s, Vogelstein developed new experimental approaches to study human tumors.

[ 5 ] His studies of various stages of colorectal cancers led him to propose a specific model for human tumorigenesis in 1988. In particular, he suggested that "cancer is caused by sequential mutations of specific oncogenes and tumor suppressor genes".

[ 6 ] [ 7 ] [ 8 ] The first tumor suppressor gene validating this hypothesis was that encoding p53 . The p53 protein was discovered 10 years earlier by several groups, including that of David Lane and Lionel Crawford , Arnold Levine , and Lloyd Old . But there was no evidence that p53 played a major role in human cancers, and the gene encoding p53 (TP53) was thought to be an oncogene rather than a tumor suppressor gene. In 1989, Vogelstein and his students discovered that TP53 not only played a role in human tumorigenesis, but that it was a common denominator of human tumors, mutated in the majority of them.

[ 9 ] [ 10 ] He then discovered the mechanism through which TP53 suppresses tumorigenesis. Prior to these studies, the only biochemical function attributed to p53 was its binding to heat shock proteins. Vogelstein and his colleagues demonstrated that p53 had a much more specific activity: it bound DNA in a sequence-specific manner. They precisely defined its consensus recognition sequence and showed that virtually all p53 mutations found in tumors resulted in loss of the sequence-specific transcriptional activation properties of p53.

[ 11 ] [ 12 ] They subsequently discovered genes that are directly activated by p53 to control cell birth and cell death.

[ 13 ] [ 14 ] His group's more recent studies examining the entire compendium of human genes have shown that the TP53 gene is more frequently mutated in cancers than any other gene .

[ 15 ] [ 16 ] [ 12 ] [ 17 ] [ 18 ] [ 19 ] In 1991, Vogelstein and long-time colleague Kenneth W. Kinzler , working with Yusuke Nakamura in Japan, discovered another tumor suppressor gene. This gene, called APC , was responsible for Familial Adenomatous Polyposis (FAP), a syndrome associated with the development of numerous small benign tumors, some of which progress to cancer.

[ 20 ] [ 21 ] This gene was independently discovered by Ray White's group at the University of Utah. Vogelstein and Kinzler subsequently showed that non-hereditary (somatic) mutations of APC initiate most cases of colon and rectal cancers. They also showed how APC functions – through binding to beta-catenin and stimulating its degradation.

[ 22 ] [ 23 ] Vogelstein and Kinzler worked with Albert de la Chapelle and Lauri Aaltonen at the U. Helsinki to identify the genes responsible for Hereditary NonPolyposis Colorectal Cancer ( HNPCC ), the other major form of heritable colorectal tumorigenesis. They were the first to localize one of the major causative genes to a specific chromosomal locus through linkage studies. This localization soon led them and other groups to identify repair genes such as MSH2 and MLH1 that are responsible for most cases of this syndrome.

[ 24 ] [ 25 ] [ 26 ] [ 27 ] In the early 2000s, Vogelstein and Kinzler, working with Victor Velculescu , Aman Amer Zakar, Mustak Akbar Zakar, Bishwas Banerjee, Carmen Flohlar, Couleen Mathers, Farheen Zuber Mohmed Patel, Nicholas Papadopoulos, and others in their group, began to perform large scale experiments to identify mutations throughout the genome. They were to perform "exomic sequencing", meaning determination of the sequence of every protein-encoding gene in the human genome. The first analyzed tumors included those of the colon, breast, pancreas, and brain. These studies outlined the landscapes of human cancer genomes, later confirmed by massively parallel sequencing of many different tumor types by laboratories throughout the world.

[ 28 ] In the process of analyzing all the protein-encoding genes within cancers, Vogelstein and his colleagues discovered several novel genes that play important roles in cancer, such as PIK3CA , [ 29 ] IDH1, [ 30 ] IDH2, [ 30 ] ARID1A, [ 31 ] ARID2, ATRX, [ 32 ] DAXX, [ 32 ] MLL2, MLL3, CIC, and RNF43.

[ 33 ] [ 34 ] [ 35 ] [ 36 ] Vogelstein pioneered the idea that somatic mutations represent uniquely specific biomarkers for cancer, creating the field now called "liquid biopsies". Working with post-doctoral fellow David Sidransky in the early 1990s, he showed that such somatic mutations were detectable in the stool of colorectal cancer patients and the urine of bladder cancer patients.

[ 37 ] [ 38 ] For this purpose, they developed "Digital PCR" in which DNA molecules are examined one-by-one to determine whether they are normal or mutated.

[ 39 ] One of the techniques they invented for Digital PCR is called " BEAMing ", in which the PCR is carried out on magnetic beads in water-in-oil emulsions.

[ 40 ] BEAMing is now one of the core technologies used in some next-generation, massively parallel sequencing instruments. More recently, they developed a digital-PCR based technique called SafeSeqS, in which every DNA template molecule is recognized by a unique molecular barcode. SafeSeqS dramatically enhances the ability to identify rare variants among DNA sequences, allowing such variants to be detected when they are present in only 1 in more than 10,000 total DNA molecules.

[ 41 ] [ 42 ] [ 43 ] [ 44 ] [ 45 ] In mid-2019, Vogelstein started collaborating with the group of Martin Nowak at Harvard University . Together with their groups, they developed mathematical models to explain the evolution of resistance against targeted therapies.

[ 46 ] They showed that the sequential administration of multiple targeted drugs precludes any chance for cure — even when there are no possible mutations that can confer cross-resistance to both drugs.  Thus, simultaneous combination of targeted therapies (as opposed to sequential) is the preferred strategy as there is at least a potential for cure.

[ 47 ] Citations [ edit ] Vogelstein has published nearly 600 scientific papers. Vogelstein's research papers have been cited over 430,000 times.

[ 48 ] In 2016 Semantic Scholar AI program included Vogelstein on its list of top ten most influential biomedical researchers.

[ 49 ] Awards [ edit ] 1990 – The Bristol Myers Squibb Award for "Distinguished Achievement in Cancer Research" [ 50 ] 1992 – The Young Investigator Award from the American Federation for Clinical Research, now the American Federation for Medical Research 1992 – The Gairdner Foundation International Award in Science [ 51 ] 1992 – The American Cancer Society Medal of Honor 1993 – The Shacknai Memorial Prize from the Hebrew University [ 52 ] 1993 – The Pezcoller Foundation Award from the American Association for Cancer Research [ 53 ] 1993 – The Richard Lounsbery Award from the National Academy of Sciences [ 54 ] 1993 – The Baxter Award from the Association of American Medical Colleges [ 55 ] 1994 – The Dickson Prize from the University of Pittsburgh 1994 – The Ernst Schering Prize [ 56 ] 1994 – The Passano Award from the Passano Foundation [ 57 ] 1994 – The Howard Taylor Ricketts Award from the University of Chicago [ 58 ] 1995 – The David A. Karnofsky Memorial Award from the American Society of Clinical Oncology [ 59 ] 1995 – The Clowes Memorial Award from the American Association for Cancer Research [ 60 ] 1997 – The William Beaumont Prize in Gastroenterology from the American Gastroenterological Association [ 61 ] 1997 – Golden Plate Award of the American Academy of Achievement [ 62 ] 1998 – The Louisa Gross Horwitz Prize [ 63 ] 1998 – The Paul Ehrlich and Ludwig Darmstaedter Prize from the Paul Ehrlich Foundation [ 64 ] 1998 – The William Allan Award from the American Society of Human Genetics [ 65 ] 2000 – The Charles S. Mott Prize from the General Motors Cancer Research Foundation 2001 – The Harvey Prize in Human Health from the Technion [ 66 ] 2001 – The Association for Molecular Pathology Award for Excellence in Molecular Diagnostics [ 67 ] 2003 – The John Scott Award from the John Scott Trust [ 68 ] 2004 – The Prince of Asturias Awards in Science [ 69 ] 2007 – The Pasarow Award for Medical Research 2011 – The Charles Rodolphe Brupbacher Prize for Cancer Research [ 70 ] 2012 – The New York Academy of Medicine Medal for Distinguished Contributions to Biomedical Science 2012 – The Pioneer in Science Award from the American Research Forum 2013 – Breakthrough Prize in Life Sciences [ 71 ] 2014 – Warren Triennial Prize [ 2 ] [ 72 ] 2015 – Dr. Paul Janssen Award for Biomedical Research [ 73 ] 2018 – The Dan David Prize for Personalized Medicine [ 74 ] [ 75 ] 2019 – Gruber Prize in Genetics [ 76 ] 2019 – Albany Medical Center Prize [ 77 ] 2020 – The Times 'Science Power List' [ 78 ] 2021 – Japan Prize [ 79 ] Affiliations [ edit ] 1968 – Alpha Epsilon Delta 1969 – Phi Beta Kappa 1992 – The American Academy of Arts & Sciences 1992 – The National Academy of Sciences, USA 1995 – Alpha Omega Alpha 1995 – The American Philosophical Society [ 80 ] 2001 – The Institute of Medicine 2005 – European Molecular Biology Organization (EMBO) References [ edit ] ^ "Breakthrough Prize – Life Sciences Breakthrough Prize Laureates – Bert Vogelstein" .

breakthroughprize.org .

^ a b "Mass. General Hospital's Warren Triennial Prize to honor Bert Vogelstein, MD - Massachusetts General Hospital, Boston, MA" . Archived from the original on 2015-02-21 . Retrieved 2015-02-21 .

^ Landau, Misia (1 January 2015).

"An Interview with Bert Vogelstein and Kenneth Kinzler" .

Clinical Chemistry .

61 (1): 9– 20.

doi : 10.1373/clinchem.2014.223271 .

PMID 25550474 – via clinchem.aaccjnls.org.

^ "Interview with Bert Vogelstein" . Archived from the original on 2013-06-03 . Retrieved 2010-04-30 .

^ Vogelstein B, Fearon ER, Hamilton SR, Feinberg AP (1985). "Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors".

Science .

227 (4687): 642– 5.

Bibcode : 1985Sci...227..642V .

doi : 10.1126/science.2982210 .

PMID 2982210 .

^ Fearon ER, Hamilton SR, Vogelstein B (1987). "Clonal analysis of human colorectal tumors".

Science .

238 (4824): 193– 7.

Bibcode : 1987Sci...238..193F .

doi : 10.1126/science.2889267 .

PMID 2889267 .

^ Vogelstein B; Fearon ER; Hamilton SR; Kern SE; Preisinger AC; Leppert M; Nakamura Y; White R; Smits AM; Bos JL (1988). "Genetic alterations during colorectal-tumor development".

N Engl J Med .

319 (9): 525– 32.

doi : 10.1056/NEJM198809013190901 .

PMID 2841597 .

^ Fearon ER, Vogelstein B (June 1990).

"A genetic model for colorectal tumorigenesis" .

Cell .

61 (5): 759– 67.

doi : 10.1016/0092-8674(90)90186-i .

PMID 2188735 .

S2CID 22975880 .

^ Baker SJ, Fearon ER, Nigro JM, et al. (April 1989). "Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas".

Science .

244 (4901): 217– 21.

Bibcode : 1989Sci...244..217B .

doi : 10.1126/science.2649981 .

PMID 2649981 .

^ Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P (1989). "Mutations in the p53 gene occur in diverse human tumour types".

Nature .

342 (6250): 705– 8.

Bibcode : 1989Natur.342..705N .

doi : 10.1038/342705a0 .

hdl : 2027.42/62925 .

PMID 2531845 .

S2CID 4353980 .

^ el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B (April 1992). "Definition of a consensus binding site for p53".

Nature Genetics .

1 (1): 45– 49.

doi : 10.1038/ng0492-45 .

PMID 1301998 .

S2CID 1710617 .

^ a b Kern SE; Pietenpol JA; Thiagalingam S; Seymour A; Kinzler KW; Vogelstein B (May 1992). "Oncogenic forms of p53 inhibit p53-regulated gene expression".

Science .

256 (5058): 827– 30.

Bibcode : 1992Sci...256..827K .

doi : 10.1126/science.1589764 .

PMID 1589764 .

^ el-Deiry WS; Tokino T; Velculescu VE; Levy DB; Parsons R; Trent JM; Lin D; Mercer WE; Kinzler KW; Vogelstein B. (November 1993).

"WAF1, a potential mediator of p53 tumor suppression" .

Cell .

75 (4): 817– 825.

doi : 10.1016/0092-8674(93)90500-P .

PMID 8242752 .

^ Yu J; Zhang L; Hwang PM; Kinzler KW; Vogelstein B. (March 2001).

"PUMA induces the rapid apoptosis of colorectal cancer cells" .

Mol Cell .

7 (3): 673– 82.

doi : 10.1016/s1097-2765(01)00213-1 .

PMID 11463391 .

^ Kern SE, Kinzler KW, Bruskin A, et al. (June 1991). "Identification of p53 as a sequence-specific DNA-binding protein".

Science .

252 (5013): 1708– 11.

Bibcode : 1991Sci...252.1708K .

doi : 10.1126/science.2047879 .

PMID 2047879 .

S2CID 19647885 .

^ el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B (1992). "Definition of a consensus binding site for p53".

Nat Genet .

1 (1): 45– 9.

doi : 10.1038/ng0492-45 .

PMID 1301998 .

S2CID 1710617 .

^ el-Deiry WS, Tokino T, Velculescu VE, et al. (November 1993).

"WAF1, a potential mediator of p53 tumor suppression" .

Cell .

75 (4): 817– 25.

doi : 10.1016/0092-8674(93)90500-P .

PMID 8242752 .

^ Waldman T, Kinzler KW, Vogelstein B (1995). "p21 is necessary for the p53-mediated G1 arrest in human cancer cells".

Cancer Res .

55 (22): 5187– 90.

PMID 7585571 .

^ Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L (February 2003).

"PUMA mediates the apoptotic response to p53 in colorectal cancer cells" .

Proc. Natl. Acad. Sci. U.S.A .

100 (4): 1931– 6.

Bibcode : 2003PNAS..100.1931Y .

doi : 10.1073/pnas.2627984100 .

PMC 149936 .

PMID 12574499 .

^ Kinzler KW, Nilbert MC, Su LK, et al. (August 1991). "Identification of FAP locus genes from chromosome 5q21".

Science .

253 (5020): 661– 5.

Bibcode : 1991Sci...253..661K .

doi : 10.1126/science.1651562 .

PMID 1651562 .

^ Nishisho I, Nakamura Y, Miyoshi Y, et al. (August 1991). "Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients".

Science .

253 (5020): 665– 9.

Bibcode : 1991Sci...253..665N .

doi : 10.1126/science.1651563 .

PMID 1651563 .

^ Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B, Kinzler KW (1992). "APC mutations occur early during colorectal tumorigenesis".

Nature .

359 (6392): 235– 7.

Bibcode : 1992Natur.359..235P .

doi : 10.1038/359235a0 .

PMID 1528264 .

S2CID 4277817 .

^ Su LK, Vogelstein B, Kinzler KW (December 1993). "Association of the APC tumor suppressor protein with catenins".

Science .

262 (5140): 1734– 7.

Bibcode : 1993Sci...262.1734S .

doi : 10.1126/science.8259519 .

PMID 8259519 .

^ Peltomäki P, Aaltonen LA, Sistonen P, Pylkkänen L, Mecklin JP, Järvinen H, Green JS, Jass JR, Weber JL, Leach FS (1993). "Genetic mapping of a locus predisposing to human colorectal cancer".

Science .

260 (5109): 810– 2.

Bibcode : 1993Sci...260..810P .

doi : 10.1126/science.8484120 .

PMID 8484120 .

^ Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomäki P, Sistonen P, Aaltonen LA, Nyström-Lahti M (1993).

"Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer" .

Cell .

75 (6): 1215– 25.

doi : 10.1016/0092-8674(93)90330-s .

PMID 8261515 .

S2CID 23321982 .

^ Papadopoulos N, Nicolaides NC, Wei YF, et al. (March 1994). "Mutation of a mutL homolog in hereditary colon cancer".

Science .

263 (5153): 1625– 9.

Bibcode : 1994Sci...263.1625P .

doi : 10.1126/science.8128251 .

PMID 8128251 .

^ Nicolaides NC, Papadopoulos N, Liu B, et al. (September 1994). "Mutations of two PMS homologues in hereditary nonpolyposis colon cancer".

Nature .

371 (6492): 75– 80.

Bibcode : 1994Natur.371...75N .

doi : 10.1038/371075a0 .

PMID 8072530 .

S2CID 4244907 .

^ Wood LD, Parsons DW, Jones S, et al. (November 2007). "The genomic landscapes of human breast and colorectal cancers".

Science .

318 (5853): 1108– 13.

Bibcode : 2007Sci...318.1108W .

CiteSeerX 10.1.1.218.5477 .

doi : 10.1126/science.1145720 .

PMID 17932254 .

S2CID 7586573 .

^ Samuels Y , Wang Z, Bardelli A , et al. (April 2004). "High frequency of mutations of the PIK3CA gene in human cancers".

Science .

304 (5670): 554.

doi : 10.1126/science.1096502 .

PMID 15016963 .

S2CID 10147415 .

^ a b Yan H, Parsons DW, Jin G, et al. (February 2009).

"IDH1 and IDH2 mutations in gliomas" .

N. Engl. J. Med .

360 (8): 765– 73.

doi : 10.1056/NEJMoa0808710 .

PMC 2820383 .

PMID 19228619 .

^ Jones S, Wang TL, Shih IeM Mao TL, Nakayama K, Roden R, Glas R, Slamon D, Diaz LA Jr, Vogelstein B, Kinzler KW, Velculescu VE, Papadopoulos N (2010).

"Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma" .

Science .

330 (6001): 228– 31.

Bibcode : 2010Sci...330..228J .

doi : 10.1126/science.1196333 .

PMC 3076894 .

PMID 20826764 .

^ a b Jiao Y, Shi C, Edil BH, et al. (March 2011).

"DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors" .

Science .

331 (6021): 1199– 203.

Bibcode : 2011Sci...331.1199J .

doi : 10.1126/science.1200609 .

PMC 3144496 .

PMID 21252315 .

^ Jones S, Zhang X, Parsons DW, et al. (September 2008).

"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses" .

Science .

321 (5897): 1801– 6.

Bibcode : 2008Sci...321.1801J .

doi : 10.1126/science.1164368 .

PMC 2848990 .

PMID 18772397 .

^ Parsons DW, Jones S, Zhang X, et al. (September 2008).

"An integrated genomic analysis of human glioblastoma multiforme" .

Science .

321 (5897): 1807– 12.

Bibcode : 2008Sci...321.1807P .

doi : 10.1126/science.1164382 .

PMC 2820389 .

PMID 18772396 .

^ Jones S, Hruban RH, Kamiyama M, et al. (April 2009).

"Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene" .

Science .

324 (5924): 217.

Bibcode : 2009Sci...324..217J .

doi : 10.1126/science.1171202 .

PMC 2684332 .

PMID 19264984 .

^ Bettegowda C, Agrawal N, Jiao Y, Sausen M, Wood LD, Hruban RH, Rodriguez FJ, Cahill DP, McLendon R, Riggins G, Velculescu VE, Oba-Shinjo SM, Marie SK, Vogelstein B, Bigner D, Yan H, Papadopoulos N, Kinzler KW (2011).

"Mutations in CIC and FUBP1 contribute to human oligodendroglioma" .

Science .

333 (6048): 1453– 5.

Bibcode : 2011Sci...333.1453B .

doi : 10.1126/science.1210557 .

PMC 3170506 .

PMID 21817013 .

^ Sidransky D, Von Eschenbach A, Tsai YC, Jones P, Summerhayes I, Marshall F, Paul M, Green P, Hamilton SR, Frost P, et al. (May 1991). "Identification of p53 gene mutations in bladder cancers and urine samples".

Science .

252 (5006): 706– 709.

Bibcode : 1991Sci...252..706S .

doi : 10.1126/science.2024123 .

PMID 2024123 .

^ Sidransky D; Tokino T; Hamilton SR; Kinzler KW; Levin B; Frost P; Vogelstein B. (March 2001). "Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors".

Science .

7 (5053): 102– 105.

doi : 10.1126/science.1566048 .

PMID 1566048 .

^ Vogelstein B, Kinzler KW (August 1999).

"Digital PCR" .

Proc. Natl. Acad. Sci. U.S.A .

96 (16): 9236– 41.

Bibcode : 1999PNAS...96.9236V .

doi : 10.1073/pnas.96.16.9236 .

PMC 17763 .

PMID 10430926 .

^ Dressman D, Yan H, Traverso G, Kinzler KW, Vogelstein B (July 2003).

"Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations" .

Proc. Natl. Acad. Sci. U.S.A .

100 (15): 8817– 22.

Bibcode : 2003PNAS..100.8817D .

doi : 10.1073/pnas.1133470100 .

PMC 166396 .

PMID 12857956 .

^ Diehl F; Li M; Dressman D; He Y; Shen D; Szabo S; Diaz LA Jr; Goodman SN; David KA; Juhl H; Kinzler KW; Vogelstein B. (November 2005).

"Detection and quantification of mutations in the plasma of patients with colorectal tumors" .

Proc. Natl. Acad. Sci. U.S.A .

102 (45): 16368– 73.

Bibcode : 2005PNAS..10216368D .

doi : 10.1073/pnas.0507904102 .

PMC 1283450 .

PMID 16258065 .

^ Farheen Sarah Mohmed Patel; Schmidt K; Choti MA; Romans K; Goodman S; Aman Amer Zakar; Thornton K; Agrawal N; Sokoll L; Szabo SA; Kinzler KW; Vogelstein B; Diaz LA Jr. (September 2018).

"Circulating mutant DNA to assess tumor dynamics" .

Nat. Med .

14 (9): 985– 90.

doi : 10.1038/nm.1789 .

PMC 2820391 .

PMID 18670422 .

^ Kinde I; Bettegowda C; Wang Y; Wu J; Agrawal N; Shih IeM; Kurman R; Dao F; Levine DA; Giuntoli R; Roden R; Eshleman JR; Carvalho JP; Marie SK; Papadopoulos N; Kinzler KW; Vogelstein B; Diaz LA Jr. (January 2013).

"Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers" .

Sci Transl Med .

5 (167): 167.

doi : 10.1126/scitranslmed.3004952 .

PMC 3757513 .

PMID 23303603 .

^ Bettegowda C; Sausen M; Leary RJ; Kinde I; Wang Y; Agrawal N; Bartlett BR; Wang H; Luber B; Alani RM; Antonarakis ES; Azad NS; Bardelli A; Brem H; Cameron JL; Lee CC; Fecher LA; Gallia GL; Gibbs P; Le D; Giuntoli RL; Goggins M; Hogarty MD; Holdhoff M; Hong SM; Jiao Y; Juhl HH; Kim JJ; Siravegna G; Laheru DA; Lauricella C; Lim M; Lipson EJ; Marie SK; Netto GJ; Oliner KS; Olivi A; Olsson L; Riggins GJ; Sartore-Bianchi A; Schmidt K; Shih lM; Oba-Shinjo SM; Siena S; Theodorescu D; Tie J; Harkins TT; Veronese S; Wang TL; Weingart JD; Wolfgang CL; Wood LD; Xing D; Hruban RH; Wu J; Allen PJ; Schmidt CM; Choti MA; Velculescu VE; Kinzler KW; Vogelstein B; Papadopoulos N; Diaz LA Jr. (February 2014).

"Detection of circulating tumor DNA in early- and late-stage human malignancies" .

Sci Transl Med .

6 (224): 224ra24.

doi : 10.1126/scitranslmed.3007094 .

PMC 4017867 .

PMID 24553385 .

^ Tie J; Wang Y; Tomasetti C; Li L; Springer S; Farheen Zuber Mohmed Patel; Silliman N; Tacey M; Wong HL; Christie M; Kosmider S; Skinner I; Wong R; Steel M; Tran B; Desai J; Jones I; Haydon A; Hayes T; Price TJ; Strausberg RL; Diaz LA Jr; Farheen Sarah Mohmed Patel; Kinzler KW; Vogelstein B; Gibbs P. (July 2016).

"Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer" .

Sci Transl Med .

8 (346): 346ra92.

doi : 10.1126/scitranslmed.aaf6219 .

PMC 5346159 .

PMID 27384348 .

^ Diaz; et al. (June 28, 2012).

"The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers" .

Nature .

486 (7404): 537– 540.

Bibcode : 2012Natur.486..537D .

doi : 10.1038/nature11219 .

PMC 3436069 .

PMID 22722843 .

^ Bozic; Reiter; Farheen Zuber Mohmed Patel; et al. (June 25, 2017).

"Evolutionary dynamics of cancer in response to targeted combination therapy" .

eLife .

2 (e00747): e00747.

doi : 10.7554/eLife.00747 .

PMC 3691570 .

PMID 23805382 .

^ "1360 Highly Cited Researchers (h>100) according to their Google Scholar Citations public profiles" . Retrieved 1 February 2017 .

^ "Who's the most influential biomedical scientist? Computer program guided by artificial intelligence says it knows" .

Science | AAAS . 17 October 2017 . Retrieved 16 June 2021 .

^ "Bristol Myers Squibb Award" (PDF) . Archived from the original (PDF) on 2012-11-14 . Retrieved 2015-04-02 .

^ "Past Recipients / Bert Vogelstein" .

Canada Gairdner Award web site .

^ "Team BCPS: creating a culture of deliberate excellence, Baltimore County Public Schools" . Archived from the original on 2017-09-20 . Retrieved 2015-04-02 .

^ "Nominations Open for 2010 Pezcoller Foundation–AACR International Award for Cancer Research" .

www.newswise.com .

^ "Richard Lounsbery Award" . National Academy of Sciences . Retrieved 17 October 2022 .

^ Baxter Award ^ "Bert Vogelstein Ernst Schering Prize 1994" . Schering Stiftung . Retrieved 17 October 2022 .

^ "Passano Award" . Archived from the original on 2016-02-09 . Retrieved 2015-04-02 .

^ "Howard T. Ricketts Prize and Lecture -" .

biologicalsciences.uchicago.edu . University of Chicago . Retrieved 17 October 2022 .

^ David A. Karnofsky Memorial Award ^ "AACR-G.H.A. Clowes Award for Outstanding Basic Cancer Research: Past Recipients" .

^ William Beaumont Prize ^ "Golden Plate Awardees of the American Academy of Achievement" .

www.achievement.org .

American Academy of Achievement .

^ "Horwitz Prize Awardees" .

cuimc.columbia.ed . Columbia University. 20 June 2018 . Retrieved 17 October 2022 .

^ "Prize Winners of the Paul Ehrlich and Ludwig Darmstaedter Prize" (PDF) . The Paul Ehrlich Foundation . Retrieved 17 October 2022 .

^ "Past Award Recipients - William Allan Award" .

ASHG . American Society of Human Genetics . Retrieved 17 October 2022 .

^ "Harvey Prize" . Technion Web Development Group . Retrieved 17 October 2022 .

^ "Association for Molecular Pathology Award Honors" .

^ "John Scott Award recipients" . Archived from the original on 2010-07-01.

^ "Prince of Asturias Award for Technical & Scientific Research 2004" .

The Prince of Asturias Foundation .

^ "Cancer Research Prize" . Charles Rodolphe Brupbacher Foundation. Archived from the original on 2015-04-03.

^ "Breakthrough Prize – Life Sciences Breakthrough Prize Laureates – Bert Vogelstein" . BreakThroughPrize . Retrieved 17 October 2022 .

^ Warren Triennial Prize ^ "Bert Vogelstein, M.D., Wins 2015 Dr. Paul Janssen Award" . UAB "JOHNSON & JOHNSON". 17 June 2015 . Retrieved 17 October 2022 .

^ "US researchers receive Dan David Prize for outstanding cancer research" .

The Jerusalem Post | JPost.com . 8 February 2018 . Retrieved 2020-04-21 .

^ "May 2018: Dan David Prize laureates in Personalized Medicine" .

physics.tau.ac.il . Retrieved 2020-04-21 .

^ "2019 Gruber Genetics Prize" . The Gruber Foundation . Retrieved 17 October 2022 .

^ "Albany Medical Center Announces Winners Of Prize In Medicine" . WAMC Northeast Public Radio. 24 September 2019 . Retrieved 17 October 2022 .

^ Franklin-Wallis, Oliver (23 May 2020).

"From pandemics to cancer: the science power list" .

The Times .

ISSN 0140-0460 . Retrieved 2020-05-26 .

^ "The Japan Prize Foundation" .

www.japanprize.jp .

^ "APS Member History" .

search.amphilsoc.org . Retrieved 2021-12-16 .

External links [ edit ] The Official Site of Louisa Gross Horwitz Prize Howard Hughes Medical Institute Bio Science watch interview v t e Breakthrough Prize laureates Mathematics Simon Donaldson , Maxim Kontsevich , Jacob Lurie , Terence Tao and Richard Taylor (2015) Ian Agol (2016) Jean Bourgain (2017) Christopher Hacon , James McKernan (2018) Vincent Lafforgue (2019) Alex Eskin (2020) Martin Hairer (2021) Takuro Mochizuki (2022) Daniel A. Spielman (2023) Simon Brendle (2024) Dennis Gaitsgory (2025) Fundamental physics Nima Arkani-Hamed , Alan Guth , Alexei Kitaev , Maxim Kontsevich , Andrei Linde , Juan Maldacena , Nathan Seiberg , Ashoke Sen , Edward Witten (2012) Special : Stephen Hawking , Peter Jenni , Fabiola Gianotti (ATLAS), Michel Della Negra , Tejinder Virdee , Guido Tonelli , Joseph Incandela (CMS) and Lyn Evans (LHC) (2013) Alexander Polyakov (2013) Michael Green and John Henry Schwarz (2014) Saul Perlmutter and members of the Supernova Cosmology Project ; Brian Schmidt , Adam Riess and members of the High-Z Supernova Team (2015) Special : Ronald Drever , Kip Thorne , Rainer Weiss and contributors to LIGO project (2016) Yifang Wang , Kam-Biu Luk and the Daya Bay team , Atsuto Suzuki and the KamLAND team, Kōichirō Nishikawa and the K2K / T2K team, Arthur B. McDonald and the Sudbury Neutrino Observatory team, Takaaki Kajita and Yōichirō Suzuki and the Super-Kamiokande team (2016) Joseph Polchinski , Andrew Strominger , Cumrun Vafa (2017) Charles L. Bennett , Gary Hinshaw , Norman Jarosik , Lyman Page Jr.

, David Spergel (2018) Special : Jocelyn Bell Burnell (2018) Charles Kane and Eugene Mele (2019) Special : Sergio Ferrara , Daniel Z. Freedman , Peter van Nieuwenhuizen (2019) The Event Horizon Telescope Collaboration (2020) Eric Adelberger , Jens H. Gundlach and Blayne Heckel (2021) Special : Steven Weinberg (2021) Hidetoshi Katori and Jun Ye (2022) Charles H. Bennett , Gilles Brassard , David Deutsch , Peter W. Shor (2023) John Cardy and Alexander Zamolodchikov (2024) Life sciences Cornelia Bargmann , David Botstein , Lewis C. Cantley , Hans Clevers , Titia de Lange , Napoleone Ferrara , Eric Lander , Charles Sawyers , Robert Weinberg , Shinya Yamanaka and Bert Vogelstein (2013) James P. Allison , Mahlon DeLong , Michael N. Hall , Robert S. Langer , Richard P. Lifton and Alexander Varshavsky (2014) Alim Louis Benabid , Charles David Allis , Victor Ambros , Gary Ruvkun , Jennifer Doudna and Emmanuelle Charpentier (2015) Edward Boyden , Karl Deisseroth , John Hardy , Helen Hobbs and Svante Pääbo (2016) Stephen J. Elledge , Harry F. Noller , Roeland Nusse , Yoshinori Ohsumi , Huda Zoghbi (2017) Joanne Chory , Peter Walter , Kazutoshi Mori , Kim Nasmyth , Don W. Cleveland (2018) C. Frank Bennett and Adrian R. Krainer , Angelika Amon , Xiaowei Zhuang , Zhijian Chen (2019) Jeffrey M. Friedman , Franz-Ulrich Hartl , Arthur L. Horwich , David Julius , Virginia Man-Yee Lee (2020) David Baker , Catherine Dulac , Dennis Lo , Richard J. Youle [ de ] (2021) Jeffery W. Kelly , Katalin Karikó , Drew Weissman , Shankar Balasubramanian , David Klenerman and Pascal Mayer (2022) Clifford P. Brangwynne , Anthony A. Hyman , Demis Hassabis , John Jumper , Emmanuel Mignot , Masashi Yanagisawa (2023) Carl June , Michel Sadelain , Sabine Hadida , Paul Negulescu , Fredrick Van Goor , Thomas Gasser , Ellen Sidransky and Andrew Singleton (2024) v t e Japan Prize recipients 1980s John R. Pierce / Ephraim Katchalski-Katzir (1985) David Turnbull / Willem J. Kolff (1986) Henry Beachell / Gurdev Khush / Theodore Maiman (1987) Georges Vendryes / Donald Henderson / Isao Arita / Frank Fenner / Luc Montagnier / Robert Gallo (1988) Frank Sherwood Rowland / Elias James Corey (1989) 1990s Marvin Minsky / W. Jason Morgan / Dan McKenzie / Xavier Le Pichon (1990) Jacques-Louis Lions / John J. Wild (1991) Gerhard Ertl / Ernest John Christopher Polge (1992) Frank Press / Kary B. Mullis (1993) William Hayward Pickering / Arvid Carlsson (1994) Nick Holonyak Jr. / Edward F. Knipling (1995) Charles K. Kao / Masao Ito (1996) Takashi Sugimura / Bruce Ames / Joseph Engelberger / Hiroyuki Yoshikawa (1997) Leo Esaki / Jozef Schell / Marc Van Montagu (1998) W. Wesley Peterson / Jack L. Strominger / Don Craig Wiley (1999) 2000s Ian McHarg / Kimishige Ishizaka (2000) John B. Goodenough / Timothy R. Parsons (2001) Tim Berners-Lee / Anne McLaren / Andrzej Tarkowski (2002) Benoit Mandelbrot / James A. Yorke / Seiji Ogawa (2003) Kenichi Honda / Akira Fujishima / Keith J. Sainsbury / John H. Lawton (2004) Makoto Nagao / Masatoshi Takeichi / Erkki Ruoslahti (2005) John Houghton / Akira Endo (2006) Albert Fert / Peter Grünberg / Peter Shaw Ashton (2007) Vint Cerf / Robert E. Kahn / Victor A. McKusick (2008) Dennis Meadows / David E. Kuhl (2009) 2010s Shun-ichi Iwasaki / Peter Vitousek (2010) Ken Thompson / Dennis Ritchie / Tadamitsu Kishimoto / Toshio Hirano (2011) Janet Rowley / Brian Druker / Nicholas Lydon / Masato Sagawa (2012) C. Grant Willson / Jean Fréchet / John Frederick Grassle (2013) Yasuharu Suematsu / C. David Allis (2014) Yutaka Takahasi / Theodore Friedmann / Alain Fischer (2015) Hideo Hosono / Steven D. Tanksley (2016) Emmanuelle Charpentier / Jennifer Doudna / Adi Shamir (2017) Akira Yoshino / Max Dale Cooper / Jacques Miller (2018) Yoshio Okamoto / Rattan Lal (2019) 2020s Robert G. Gallager / Svante Pääbo (2020) Martin A. Green / Bert Vogelstein / Robert A. Weinberg (2021) Katalin Karikó / Drew Weissman / Christopher Field (2022) Masataka Nakazawa / Kazuo Hagimoto / Gero Miesenböck / Karl Deisseroth (2023) Brian Hoskins / John Michael Wallace / Ronald M. Evans (2024) v t e Laureates of the Prince or Princess of Asturias Award for Technical and Scientific Research Prince of Asturias Award for Technical and Scientific Research 1981: Alberto Sols 1982: Manuel Ballester 1983: Luis Antonio Santaló Sors 1984: Antonio Garcia-Bellido 1985: David Vázquez Martínez and Emilio Rosenblueth 1986: Antonio González González 1987: Jacinto Convit and Pablo Rudomín 1988: Manuel Cardona and Marcos Moshinsky 1989: Guido Münch 1990: Santiago Grisolía and Salvador Moncada 1991: Francisco Bolívar Zapata 1992: Federico García Moliner 1993: Amable Liñán 1994: Manuel Patarroyo 1995: Manuel Losada Villasante and Instituto Nacional de Biodiversidad of Costa Rica 1996: Valentín Fuster 1997: Atapuerca research team 1998: Emilio Méndez Pérez and Pedro Miguel Echenique Landiríbar 1999: Ricardo Miledi and Enrique Moreno González 2000: Robert Gallo and Luc Montagnier 2001: Craig Venter , John Sulston , Francis Collins , Hamilton Smith , and Jean Weissenbach 2002: Lawrence Roberts , Robert E. Kahn , Vinton Cerf , and Tim Berners-Lee 2003: Jane Goodall 2004: Judah Folkman , Tony Hunter , Joan Massagué , Bert Vogelstein , and Robert Weinberg 2005: Antonio Damasio 2006: Juan Ignacio Cirac 2007: Peter Lawrence and Ginés Morata 2008: Sumio Iijima , Shuji Nakamura , Robert Langer , George M. Whitesides , and Tobin Marks 2009: Martin Cooper and Raymond Tomlinson 2010: David Julius , Baruch Minke , and Linda Watkins 2011: Joseph Altman , Arturo Álvarez-Buylla , and Giacomo Rizzolatti 2012: Gregory Winter and Richard A. Lerner 2013: Peter Higgs , François Englert , and European Organization for Nuclear Research CERN 2014: Avelino Corma Canós , Mark E. Davis , and Galen D. Stucky Princess of Asturias Award for Technical and Scientific Research 2015: Emmanuelle Charpentier and Jennifer Doudna 2016: Hugh Herr 2017: Rainer Weiss , Kip S. Thorne , Barry C. Barish , and the LIGO Scientific Collaboration 2018: Svante Pääbo 2019: Joanne Chory and Sandra Myrna Díaz 2020: Yves Meyer , Ingrid Daubechies , Terence Tao , and Emmanuel Candès 2021: Katalin Karikó , Drew Weissman , Philip Felgner , Uğur Şahin , Özlem Türeci , Derrick Rossi , and Sarah Gilbert 2022: Geoffrey Hinton , Yann LeCun , Yoshua Bengio , and Demis Hassabis 2023: Jeffrey I. Gordon , Everett Peter Greenberg , and Bonnie Bassler 2024: Daniel J. Drucker , Jeffrey M. Friedman , Joel F. Habener , Jens Juul Holst , and Svetlana Mojsov 2025: Mary-Claire King Authority control databases International ISNI VIAF FAST WorldCat National United States Czech Republic Netherlands Norway Catalonia Academics ORCID Google Scholar Other IdRef Yale LUX Retrieved from " https://en.wikipedia.org/w/index.php?title=Bert_Vogelstein&oldid=1289929187 " Categories : Howard Hughes Medical Investigators Members of the United States National Academy of Sciences Richard-Lounsbery Award laureates Johns Hopkins Hospital physicians American oncologists 1949 births Members of the European Molecular Biology Organization Living people People from Baltimore County, Maryland University of Pennsylvania alumni Johns Hopkins School of Medicine alumni 20th-century American Jews 21st-century American Jews Members of the American Philosophical Society Members of the National Academy of Medicine Hidden categories: Articles with short description Short description is different from Wikidata Articles with hCards This page was last edited on 11 May 2025, at 19:04 (UTC) .

Text is available under the Creative Commons Attribution-ShareAlike 4.0 License ;
additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy . Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.

, a non-profit organization.

Privacy policy About Wikipedia Disclaimers Contact Wikipedia Code of Conduct Developers Statistics Cookie statement Mobile view Search Search Toggle the table of contents Bert Vogelstein 14 languages Add topic

